General Constitutional genetics Flashcards
(338 cards)
Question
Answer
Name 2 X-Linked Recessive disorders
- Duchenne/Becker Muscular Dystrophy (DMD/BMD)- Spinal and Bulbar Muscular Atrophy (SBMA)- Androgen Insensitivity Syndrome (AIS)
Name 2 X-Linked Dominant disorders
X-linked hypophosphatemiaX-linked Alport SyndromeRett Syndrome
Name three clinical features associated with CF
Chronic coughing and wheezingFailure to thrivePancreatic insufficiency
Name the most common CF mutation
p.Phe508del - 75%
Describe the function of CFTR (7q31.2)
Cyclic AMP-activated chloride channel located in the plasma membrane of secretory eithelial cells
Briefly describe CRISPR-Cas9
Gene editing - Cas9 protein complex containing specific sequence of RNA - once complimentary sequence is identified the DNA is cut and released into the cell. Cellular DNA repair mechanisms repair the break - but this is prone to error. By introducing templates of ‘corrected’ DNA - these specific sequences can be incorporated to replace mutant alleles
Name 3 disorders associated with FMR1
- Fragile X, 2. FXTAS,3. POI
Name 7 methods for detecting UPD
MS-PCRMS-Melt Curve AnalysisMS-MLPAMS-PyrosequencingMicrosatellite analysisSNP ArraysWGS/WES - trios especially powerful
Name 3 methods of detecting UPD that rely on bisulphite conversion
MS-PCRMS-Melt Curve AnalysisMS-Pyrosequencing
What are the pros and cons of using microsatellite analysis for UPD detection?
Pros: Will distinguish whole/partial UPD and Hetero/Isodisomy, relatively cheap, no prior conversion step, reliable methodCons: Need parental samples and informative markers
Describe MS-MLPA
2 tubes, 1 for CNV, 1 for methylation specific enzyme digest. Methylated DNA won’t digest, and then will amplify during MLPA.Semi quantitative,no parental bloods needed, can distinguish UPD from deletion from a small amount of DNAcan’t distinguish UPD and mutation in imprinting centre
How can you use WGS/WES for detection of UPD?
Trio analysis - bioinformatic pipelines will check for identity by looking for biparental inheritanceCan detect mosaics and can distinguish full range of del/UPD/IC defectExpensive and time consuming, requires parental samples
What are the pros and cons of using bisulphite conversion for UPD testing?
Pros: Allows for analysis without parental samples, bisulphite conversion kits readily available, cheap and effectiveCons: Won’t distinguish segmental/whole UPD, or del from UPD (MS-PCR)
what are antisense oligonucleotides?
ssDNA or RNA 20bp that binds to mRNA blocking the translational mechanism. The can be used to block production of abnormal protein, correct aberration by exon skipping or correct splice mutations. they are checmically modified to prevent nuclease degradation
give examples of how antisense oligos have been used to treat diseases?
- DMD - Eteplirsen (Exondys 51) in clinical use. used as reading frame correction to induce exon skipping and produce smaller partially functional protein. requires repeated treatments. it is mutation specific but due to hotspots is applicable to wide number of patients. low efficiency in heart muscle and many patients die of heart complications so need to improve AO efficiency in heart muscles - would allow lower dosage and fewer administrations2. SMA - Nusinersen (Spinraza) in clinical use enhance exon 7 inclusion in SMN2 to produce functional protein and lessen SMA caused by loss of SMN1. this results from blocking intron 7 splice site to promote exon 7 inclusion. 3. HD - IONIS-HTTRx in phase 3 trials - suppress translation of HTT mRNA containing CAG expansion. targets HTT-dependent SNPs so doesnt taget expansions in other genes.
what are the Challenges of using ASOs for the treatment of genetic diseases?
o Delivery to target tissueo Achieve sustained effect. Chemically stabilised forms of ASOs will require re-administration for most applications.o Difficult to achieve complete inhibition as there are large quantities of mRNA and lower levels of ASO within the cell.
describe CRISPR-Cas9 system and limitations
CRISPR-Cas9 is a highly cost-effective technique that allows specific targeting of gene manipulation via RNA-guided nuclease. once a cut is made, DNA with matching sticky ends can be incorporated by DNA repair mechanisms. Trials in b-thalassaemia, DMD, and freidreich ataxia. limitations:1. limited number of motifs to bind to in genome2. delivery to target cells3. although it has proofreading finction, some off target mutagenesis has been seen in similar sequences to target
describe small molecules for genetic treatment
- amnioglycosides promotes read-through of stop codons. amnioglycosides interact with A site of rRNA, altering conformation and reducing accuracy between mRNA-tRNA pairings allowing AA to be inserted instead of termination at stop codon. works best where low levels of functional protein can restore function. eg. Translana in DMD induces ribosomes to read through PTC. works on mRNA transcripts so patients with low mRNA levels may not respond. NICE approval 2. corrects folding/transport or activation of protein eg. Ivacaftor for CFTR to improve chloride channel transport (class III) or enhance folding (class II) eg. phe508del Lumacaftor.
Clinical features of HMSN1
distal muscle weaknesspes cavusfrequent trips, fallsdifficulty walking on uneven surfacesmuscle wastage in calves (inverted champagne bottle)
Molecular pathogenesis of PMP22 and disease
PMP22 expressed by Schwann cells of peripheral nerves - produces 2-5% of total myelinPMP22 dup causes increases PMP22 expression > disrupts regulation of myelin production > demyelination of peripheral nerves > abnormal axon function > reduced nerve conduction speeds and axonal lossPMP22 del > Reduced myelin > disruption of myelin junctions > impaired propogation of nerve potentials
What does HMSN stand for?
Hereditary motor and sensory neuropathy
Chromosome location for PMP22
17p12
Cause HNPP
85% caused by PMP22 deletions| 15% caused by LOF mutations in PMP22